Tomoko Sugihara
Tomoko Sugihara publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Chronic Lymphocytic Leukemia Research, Bone health and osteoporosis research and Lung Cancer Treatments and Mutations.
- World rank
- #4,748,266 of 7,710,434 ranked researchers
- Rank in United States
- #1,247,511 of 1,627,098
- Works
- 35
- Citations
- 277
- Citations per work
- 7.9
What does Tomoko Sugihara research?
Tomoko Sugihara's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1749.3%
- Medicine1749.3%
- Everything else1541.5%
- Life Sciences39.2%
- 1Pulmonary and Respiratory Medicine16% of their works
- 2Oncology12% of their works
- 3Cancer Research9% of their works
- 4Genetics8% of their works
- 5Cardiology and Cardiovascular Medicine8% of their works
- 6Orthopedics and Sports Medicine6% of their works
Research topics
Which keywords describe Tomoko Sugihara's research?
The keywords of their largest research topics: Prognostic Factors, Targeted Therapy, Clinical Trials, Chemotherapy, Chronic Lymphocytic Leukemia, Genomic Aberrations, ALK Inhibitors and Bone Mineral Density.
- Sunitinib
- Imatinib Mesylate
- Cancer Genomics
- Small-Cell Lung Cancer
- Gene Expression
- Fractures
- Bone Mineral Density
- Genomic Aberrations
- Chemotherapy
- Targeted Therapy
- Prognostic Factors
- Clinical Trials
- Chronic Lymphocytic Leukemia
- ALK Inhibitors
- EGFR Mutations
- Breast Tumours
- Genomic Profiles
- Anthracyclines
- Doxorubicin
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Prognostic Factors143 topics
- Targeted Therapy123 topics
- Clinical Trials92 topics
- Chemotherapy72 topics
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- ALK Inhibitors51 topic
- Bone Mineral Density51 topic
- EGFR Mutations51 topic
- Fractures51 topic
- Breast Tumours41 topic
- Gene Expression41 topic
- Genomic Profiles41 topic
- Small-Cell Lung Cancer41 topic
- Anthracyclines31 topic
- Cancer Genomics31 topic
- Doxorubicin31 topic
- Imatinib Mesylate31 topic
- Mutational Signatures31 topic
- Sunitinib31 topic
Where does Tomoko Sugihara work?
Tomoko Sugihara's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Tomoko Sugihara have?
OpenAlex counts 35 works and 277 citations for Tomoko Sugihara, an h-index of 10, ranking #4,748,266 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tomoko Sugihara. Posts are plain text and can be reported.